Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Kemin Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0523-686X; OpenAlex author ID A5065014516. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper

Papers 4

  1. Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12253-015-9930-y↗
  2. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer. Co-author DOI 10.3892/mmr.2014.2558↗
  3. MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. Co-author DOI 10.1007/s12253-013-9637-x↗
  4. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. Co-author DOI 10.1007/s13277-012-0446-8↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weijia Sun · 4 shared papers, 2012–2015 · strength 0.19
  2. Kun Song · 2 shared papers, 2014–2015 · strength 0.11
  3. Guo‐Huang Hu · 2 shared papers, 2013–2015 · strength 0.10
  4. Jian Li · 2 shared papers, 2013–2014 · strength 0.09
  5. Jian Li · 1 shared paper, 2015 · strength 0.06
  6. Yongjun Hu · 1 shared paper, 2012 · strength 0.04
  7. Yuxiang Chen · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.